The chi-square test was used to evaluate the correlations between HSPB1 expression and clinicopathologic features of breast cancer patients, such as age, tumor stage, LN metastasis, distant metastasis, histologic grade, ER status, PR status, HER-2 status, and Ki67 expression. This evidence concerns the gene MKI67 and breast carcinoma.